Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), the U.S. partner of Huadong Medicine Co., Ltd. (SHE: 000963), announced today that...
BeOne Medicines Ltd. (NASDAQ: ONC; HKG: 6160; SHA: 688235) announced today that the U.S. Food...
ReviR Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan...
Everest Medicines Limited (HKG: 1952) announced today that the first patient has been successfully dosed...
Boehringer Ingelheim (BI) announced today the official start‑up of its local manufacturing plan for the diabetes...
Amoytop Biotech Co. Ltd. (SHA: 688278) announced today that the National Medical Products Administration (NMPA)...
Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460) announced today that it has completed an equity...
Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd. (CTTQ), a wholly‑owned subsidiary of China‑listed Sino Biopharmaceutical Ltd....
Everest Medicines Limited (HKG: 1952) announced today that the National Medical Products Administration (NMPA) has...
China‑listed Sichuan Kelun‑Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) announced today that the National Medical Products...
China‑based Zhuhai Beihai Biotech Co., Ltd. announced today that its Category 1 innovative drug BH1621 has...
China‑based Sichuan Biokin Pharmaceutical Co., Ltd. (SHA: 688506) announced that its wholly‑owned subsidiary SystImmune, Inc....
Boehringer Ingelheim (BI) announced today that the U.S. Food and Drug Administration (FDA) has approved...
The National Medical Products Administration (NMPA) announced that Jiangxi Hemei Pharmaceutical Co., Ltd. has received...
The Chinese State Council has issued the Regulations on the Administration of Clinical Research and...
Bristol-Myers Squibb (BMS, NYSE: BMY) announced today that it will acquire Orbital Therapeutics (“Orbital”), a...
Peijia Medical Limited (HKG: 9996) announced today that the National Medical Products Administration (NMPA) of...
PegBio Co., Ltd. (HKG: 2565) announced today that it has entered into a non‑binding term...
China‑based Hangzhou Tigermed Consulting Co., Ltd. (HKG: 3347) announced that it and its subsidiary Jiaxing...
BeOne Medicines Ltd. (NASDAQ: ONC; HKG: 6160; SHA: 688235) announced today that it has terminated...